TreatHF vs Anticoagulation Manager

TreatHF is a clinical decision support app that provides clinicians individualized therapy suggestions for their symptomatic heart failure patients and provides guidance on the use of each therapy. • Enter patient indications • Review individualized next steps for medical therapy • Email or print a summary of the next steps • Reference detailed information for - Initiation, titration, and monitoring of each medication - Guidance for optimizing your overall medication strategy. Content in this app is derived from the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure, the 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction, and the 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction. The information and recommendations in this clinical decision support app are not meant to represent the only or best course of care nor replace clinical judgment. Therapeutic options should be determined after discussion between the patient and their care provider.

The Anticoagulation Manager is a mobile application developed through the collaborative efforts of the CDC and the Georgia Institute of Technology. Since the determination of the correct type and dose of anticoagulant drugs can be challenging, this application is a resource for clinicians to appropriately order laboratory testing and choose anticoagulant drugs for the various indications. It gives clinicians evidence-based, accessible, and accurate information when prescribing anticoagulants to prevent and/or treat abnormal clotting states.